Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of S-1 and Cisplatin
compared to 5-FU and Cisplatin in treatment of patients with metastatic diffuse gastric and
esophagogastric junction cancer previously untreated with chemotherapy.